Bajbouj, K.; Ramakrishnan, R.K.; Saber-Ayad, M.; Omar, H.A.; Saheb Sharif-Askari, N.; Shafarin, J.; Elmoselhi, A.B.; Ihmaid, A.; AlHaj Ali, S.; Alalool, A.;
et al. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells. Int. J. Mol. Sci. 2021, 22, 6131.
https://doi.org/10.3390/ijms22116131
AMA Style
Bajbouj K, Ramakrishnan RK, Saber-Ayad M, Omar HA, Saheb Sharif-Askari N, Shafarin J, Elmoselhi AB, Ihmaid A, AlHaj Ali S, Alalool A,
et al. PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells. International Journal of Molecular Sciences. 2021; 22(11):6131.
https://doi.org/10.3390/ijms22116131
Chicago/Turabian Style
Bajbouj, Khuloud, Rakhee K. Ramakrishnan, Maha Saber-Ayad, Hany A. Omar, Narjes Saheb Sharif-Askari, Jasmin Shafarin, Adel B. Elmoselhi, Ahmed Ihmaid, Suhib AlHaj Ali, Abdulla Alalool,
and et al. 2021. "PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells" International Journal of Molecular Sciences 22, no. 11: 6131.
https://doi.org/10.3390/ijms22116131
APA Style
Bajbouj, K., Ramakrishnan, R. K., Saber-Ayad, M., Omar, H. A., Saheb Sharif-Askari, N., Shafarin, J., Elmoselhi, A. B., Ihmaid, A., AlHaj Ali, S., Alalool, A., Abdullah, R., & Hamid, Q.
(2021). PRMT5 Selective Inhibitor Enhances Therapeutic Efficacy of Cisplatin in Lung Cancer Cells. International Journal of Molecular Sciences, 22(11), 6131.
https://doi.org/10.3390/ijms22116131